Here are five thoughts on physician-owned distributorships.

Mazor Robotics surgical guidance system Renaissance has placed 1,019 implants percutaneously, accounting for 25 percent of all cases involving Renaissance systems.

Five spine surgeons discuss what types of innovation they would like to see in the operating room in the next five years.

Stimwave Technologies in Scottsdale, Ariz., will join BioInspire in Peoria, Ariz., according to an AZ Central report.

Dayton, Ohio-based NovoSource is a startup orthopedic device firm looking to cut costs from the process of developing and selling orthopedic implants, according to Med City News.

CareFusion, a global medical technology company, reported fiscal year 2012 fourth quarter revenue at $968 million, a 3 percent increase over the same period last year.

The United States market for minimally invasive spine devices is expected to exceed $2.6 billion by 2018, according to an iData Research report.

Demand for implantable medical devices in the United States is projected to increase 7.7 percent annually to $52 billion in 2015, according to a new Freedonia report.

This article is written by Tommy Mitchell, President, CEO, Founder of OrthoDirectUSA.

Here are the top three concerns for orthopedic surgeons this year from Henry Finn, MD, FACS, medical director of the Chicago Center for Orthopedics at Weiss Memorial Hospital and professor of surgery at the University of Chicago.